Investigating the effects of CBD use during pregnancy on maternal and child health outcomes
Official title: Cannabidiol (CBD)-only use in Pregnancy and Perinatal Outcomes
Funded at University of Colorado Denver · NIH-11051487 · Data updated 2026-11-12
This study is looking at how many pregnant women use CBD during their third trimester and how it might affect their health and their baby's health, and it's for expectant moms receiving care at the University of Colorado who are willing to share their experiences and health information.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $188,482 |
| NIH project number | 1K23DA060336-01A1 |
| Project ID | NIH-11051487 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant women in their third trimester who are receiving prenatal care at the University of Colorado.
✕Less likely to help
Patients who are not pregnant or those who are not receiving prenatal care will not benefit from this research.
What this research studies
This research examines the use of cannabidiol (CBD) by pregnant women, particularly during the third trimester, to understand its prevalence and effects on maternal and child health outcomes. Pregnant individuals receiving care at the University of Colorado will participate by completing surveys and providing blood samples for cannabinoid analysis. The study aims to characterize the demographics and health profiles of women using CBD and to explore the pregnancy and birth-related outcomes associated with its use. This observational study will involve around 800 participants and will utilize electronic medical records for comprehensive data analysis.
Why it matters
Potential benefit: If successful, this research could provide valuable insights into the safety and effects of CBD use during pregnancy, potentially guiding future recommendations for pregnant women.
How similar studies have gone: While there is ongoing research into cannabis use during pregnancy, this specific focus on CBD-only use is relatively novel and has not been extensively studied.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Bhatia, Devika — University of Colorado Denver
- Study coordinator: Bhatia, Devika
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.